Promising Immunotherapy in Metastatic Testicular Sex Cord Stromal Tumours After First-Line Chemotherapy

Promising Immunotherapy in Metastatic Testicular Sex Cord Stromal Tumours After First-Line Chemotherapy

BackgroundTesticular sex cord stromal tumours (TSCSTs) are rare, with few studies focusing on the metastatic TSCST prognosis. The value of treatments, including radical orchiectomy (RO) and retroperitoneal lymph node dissection (RPLND), in preventing metastasis is controversial. Additionally, metast...

Full description

Bibliographic Details
Main Authors: Bingqing Shang, Chuanzhen Cao, Weixing Jiang, Hongzhe Shi, Xingang Bi, Chengxu Cui, Jianzhong Shou, Shan Zheng, Jin Zhang, Aiping Zhou, Changling Li, Jianhui Ma
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Immunology
Subjects:
testicular sex cord stromal tumours
metastasis
immunotherapy
immune checkpoint inhibitors
PD-1 inhibitor
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.720359/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.720359/full

Similar Items